ImmunoCAT study: study of the impact of molecular diagnosis by ImmunoCAP ISAC® 112 on allergen Immunotherapy prescription in CATalonia

Abstract

This new approach to the production of allergen product for the diagnosis and treatment of allergy could bring a generational change in our fight of allergy. With sophisticated and convivial products able define to more closely one's molecular / component allergy diagnosis at the point of care, and with potent yet safe therapeutic products closely tailored to such results, immunotherapy delivered through therapeutic vaccination could thrust Precision Medicine at the center of allergy management.